These results suggest that high TUBA1B expression may promote tumor stemness and decrease sensitivity to immunotherapy in gliomas, highlighting the potential importance of TUBA1B in glioma progression and treatment response. The gene discussed is TUBA1B; the disease is central nervous system cancer.